 Home > Active Ingredient News > Blood System > The courier is a blockbuster!

The courier is a blockbuster!

 Last Update: 2022-06-05
 Source: Internet
 Author: User

Tags

ketamine clinical trials

wuxi apptec

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

▎WuXi AppTec Content Team Editor Today, Nkarta announced that the company's two major chimeric antigen receptor (CAR) natural killer (NK) cell candidate therapies, NKX101 and NKX019, are in two early-stage treatments for different blood cancer patient populations.
Positive results in clinical trials
.

This is the first time Nkarta has announced the clinical trial results of its CAR-NK R&D program
.

The two CAR-NK therapies not only showed good safety, but also achieved complete remission in more than half of the patients who had received multiple previous treatments
.

This result also demonstrates the broad prospects of ready-to-use NK cell therapy, which has attracted widespread attention in the industry
.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Courier doubles the "cancer-free survival" time of patients with early bladder cancer, and the blockbuster PD-1 inhibitor is approved by the FDA

10-02

Related Products

Gadusol Powder Gadusol76663-30-4

CAS No.: 76663-30-4

Industrial Grade

$1-1.01/G FOB

Food Additive Iron fumarate for Nutritional Iron Supplements

CAS No.: 141-01-5

Pharmacy Grade

$24-26/G FOB

Aminobenzoic Acid CAS 56-91-7

CAS No.: 56-91-7

Pharmaceutical Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

The courier is a blockbuster!

Related Articles

Courier doubles the "cancer-free survival" time of patients with early bladder cancer, and the blockbuster PD-1 inhibitor is approved by the FDA